Yuhei Sangatsuda

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Low-grade diffusely infiltrative tumor, SMARCB1-mutant: A diagnostic challenge-case report.

Low-grade diffusely infiltrative tumor, SMARCB1-mutant: A diagnostic challenge-case report.

Journal: Journal of neuropathology and experimental neurology

Published: November 01, 2025

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 07, 2025

Sublabial and Endonasal Multicorridor Approaches to the Anterior Orbit: An Anatomic Cross-Sectional Study and Clinical Application.

Sublabial and Endonasal Multicorridor Approaches to the Anterior Orbit: An Anatomic Cross-Sectional Study and Clinical Application.

Journal: Operative neurosurgery (Hagerstown, Md.)

Published: July 16, 2025

Long-term outcome of nimustine-based chemotherapy for oligodendroglioma.

Long-term outcome of nimustine-based chemotherapy for oligodendroglioma.

Journal: Neuro-oncology advances

Published: July 02, 2025

Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma.

Hemizygous deletion of cyclin-dependent kinase inhibitor 2A/B with p16 immuno-negative and methylthioadenosine phosphorylase retention predicts poor prognosis in IDH-mutant adult glioma.

Journal: Neuro-oncology advances

Published: July 18, 2024

Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastoma.

Glutaminolysis is associated with mitochondrial pathway activation and can be therapeutically targeted in glioblastoma.

Journal: Cancer & metabolism

Published: June 14, 2024

All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma.

All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma.

Journal: Pathology, research and practice

Published: May 14, 2024

The importance of the palatine bone for endoscopic endonasal skull base surgery.

The importance of the palatine bone for endoscopic endonasal skull base surgery.

Journal: Clinical anatomy (New York, N.Y.)

Published: March 11, 2024

Preservation of nasal function in paramedian endoscopic endonasal approaches: patient series.

Preservation of nasal function in paramedian endoscopic endonasal approaches: patient series.

Journal: Journal of neurosurgery. Case lessons

Published: February 27, 2024

Role of the endonasal endoscopic approach in intraorbital tumor surgery: insights from a single-center experience.

Role of the endonasal endoscopic approach in intraorbital tumor surgery: insights from a single-center experience.

Journal: Journal of neurosurgery

Published: February 12, 2024

Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid.

Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid.

Journal: Cancers

Published: December 25, 2023

The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods.

The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods.

Journal: Neuroradiology

Published: October 21, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026